Holdings
Diadema Partners LP
As of Sep 30, 2026, Diadema Partners LP reported 72 positions worth US$212M. Largest: United Therapeutics Corporation, Cogent Biosciences, Inc. and Abivax SA. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| United Therapeutics Corporation | 46,222 | US$25M | −6,767 | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 642K | US$20.6M | +148K | Sep 30, 2026 |
| Abivax SA | 178K | US$17.7M | +14,800 | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 255K | US$15.3M | −57,463 | Sep 30, 2026 |
| Revolution Medicines, Inc. | 70,004 | US$14.4M | −69,214 | Sep 30, 2026 |
| Viking Therapeutics, Inc. | 433K | US$14.1M | −8,642 | Sep 30, 2026 |
| BridgeBio Pharma, Inc. | 104K | US$6.84M | new | Sep 30, 2026 |
| Immunocore Holdings plc | 222K | US$6.72M | new | Sep 30, 2026 |
| 4D Molecular Therapeutics, Inc. | 421K | US$6.03M | −150K | Sep 30, 2026 |
| Viridian Therapeutics, Inc. | 257K | US$5.29M | +157K | Sep 30, 2026 |